Kendric Speagle, CEO of VivaMed BioPharma, explores the challenges of traditional drug development and how VivaMed is using AI to discover and repurpose existing drugs for new treatments.
February 7, 2023
Kendric Speagle, CEO of VivaMed BioPharma, explores the challenges of traditional drug development and how VivaMed is using AI to discover and repurpose existing drugs for new treatments.
Other Interviews
